0002088152-25-000001.txt : 20251023 0002088152-25-000001.hdr.sgml : 20251023 20251023163036 ACCESSION NUMBER: 0002088152-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251023 DATE AS OF CHANGE: 20251023 EFFECTIVENESS DATE: 20251023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Triton Therapeutics, Inc. CENTRAL INDEX KEY: 0002088152 ORGANIZATION NAME: EIN: 392471221 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-561892 FILM NUMBER: 251413458 BUSINESS ADDRESS: STREET 1: 700 FAIRFIELD AVENUE, SUITE 1 CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-482-3123 MAIL ADDRESS: STREET 1: 700 FAIRFIELD AVENUE, SUITE 1 CITY: STAMFORD STATE: CT ZIP: 06902 D 1 primary_doc.xml X0708 D LIVE 0002088152 Triton Therapeutics, Inc. 700 FAIRFIELD AVENUE, SUITE 1 STAMFORD CT CONNECTICUT 06902 203-482-3123 DELAWARE None None Corporation true 2025 Paul Fonteyne 700 Fairfield Avenue Suite 1 Stamford CT CONNECTICUT 06902 Executive Officer Director Annie Mitsak 394 Newbury Street 2nd Floor Boston MA MASSACHUSETTS 02116 Director Timothy Shannon 700 Fairfield Avenue Suite 1 Stamford CT CONNECTICUT 06902 Director Elena Grigoryeva c/o Celgene Switzerland LLC Route 206 & Province Line Road Princeton NJ NEW JERSEY 08543 Director Pharmaceuticals Decline to Disclose 06b false 2025-10-17 false true false 0 36355769 36355769 0 false 4 0 0 0 No amounts other than ordinary course employment compensation is being paid to officers and directors. false Triton Therapeutics, Inc. Paul Fonteyne Paul Fonteyne President 2025-10-23